Ras, a small GTPase, functions as a molecular switch in diverse signaling pathways, controlling processes such as cell growth and differentiation. Its activity is determined by the nucleotide state—Ras-GTP represents the active “ON” state, while hydrolysis to GDP switches it “OFF”. This cycle is modulated by GAPs and GEFs. A key step in downstream signaling is the interaction between Ras-GTP and effector proteins through the Ras-binding domain (RBD), which binds Ras-GTP with nanomolar affinity at a conserved interface. We hypothesized that artificial regulation of this interaction could enable external control of Ras signaling. To achieve this, we engineered a Ca 2+ -responsive system by fusing calmodulin (CaM) and the M13 peptide to the termini of RBD. CaM undergoes conformational rearrangements upon Ca 2+ binding and specifically recognizes M13 with high affinity. Structural modeling using AlphaFold3 predicted that, under Ca 2+ -bound conditions, CaM-M13 interaction sterically occludes the Ras-binding site of RBD. Consistently, biochemical assays confirmed that Ras-RBD association was significantly inhibited in the presence of Ca 2+ . These findings demonstrate a novel ion-controlled mechanism for regulating Ras activity. Our CaM/M13-fused RBD system provides a proof-of-concept for designing ionochromic switches to modulate small GTPase signaling pathways, suggesting potential applications in synthetic biology and signal regulation.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: